PCN30 COST-EFFECTIVENESS OF APREPITANT IN PATINENTS RECEIVING ANTIEMETIC PROPHYLAXIS FOR HIGHLY EMETOGENIC CHEMOTHERAPY IN HUNGARY
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66567-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)66567-9/fulltext
Section Title :
Section Order :
402
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66567-9&doi=10.1016/S1098-3015(10)66567-9